Actemra PFS (tocilizumab) Drug / Medicine Information

2022-09-10 00:22:02 By : Ms. Rose Shu

We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia.

1. you have had an allergic reaction to Actemra or any ingredients listed at the end of this leaflet

2. you have had an allergic reaction to any other recombinant human or humanised antibodies or proteins that are of hamster origin

3. you have an active, severe infection

4. the package is torn or shows signs of tampering

5. the expiry date (EXP) printed on the pack has passed.

1. you have or develop any kind of infection

2. you have any other health problems, especially the following:

3. you are planning to have a vaccination or have recently had a vaccination

4. you are pregnant or plan to become pregnant

5. you are breast-feeding or plan to breast-feed

6. you are allergic to any other medicines, foods, dyes or preservatives

In this interview, News Medical speaks to Jeffrey Stogsdill, Ph.D., about his latest research exploring how microglia change their state to adapt to different areas of the brain.

Until recently, cells were typically counted on a reusable quartz hemocytometer.

In this interview, we speak to Morteza Sarmadi from MIT about his labs latest research that developed microparticles able to deliver self-boosting vaccines.

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

This site complies with the HONcode standard for trustworthy health information: verify here.

News-Medical.net - An AZoNetwork Site

Owned and operated by AZoNetwork, © 2000-2022